Jungla Inc. is an AI-driven biotechnology company enabling robust, scalable clinical guidance across genetic and genomic tests. (Acquired by Invitae in 2019.)
South San Francisco, CA
Joined February 2016
- Tweets25
- Following89
- Followers297
- Likes50
Pinned Tweet
Genetic and genomic testing often provides patients with unclear results – @claraya explains how Jungla can help change that for labs, providers, and patients. medium.com/@jungla/bringing-… #genomics #ai #precisionmedicine #beyondsequencing
If you’re in Seattle and excited about building a scalable, mechanistic platform for clinical genetics and genomics, come grab a beer. It’s on us: Big Time Brewery from 5:30-7:30pm (Today)!
Enhancing today’s largely observational #clinical #genetics infrastructure with a model-driven framework can bring #patients tests that are #quantitative, #auditable, #comprehensive, and increasingly #mechanistic. @MyBioTechniques interviews CEO @claraya: bit.ly/jungla-biotechniques-…
In an interview with @GenomeWeb, Jungla CEO @claraya shares why three scientists from @Stanford came together to help make genomes more meaningful. Read more about the mission that @claraya, @acolavin, and @jasonareuter have undertaken: bit.ly/2Fk4wG7
Jungla embraces transparency, utilizing blockchain to make the Molecular Evidence Platform auditable - learn more from a recent interview between cofounder @acolavin and @Tierion CEO @WayneVaughan.
tnt.tl/2RO7o17
Jungla Inc. retweeted
Variants of Unknown Significance (VUS) remain a major challenge for interpreting genomic data. @junglainc is working to advance our ability to make sense of our DNA.
ML combined with domain knowledge can push way beyond what ML can do alone. @junglainc combines ML with several other methods, including insights from biophysics, cellular engineering, and distributed systems, to make considerably more accurate predictions of genomic variants.
Jungla Inc. retweeted
10+ new tests *each day* in US, yet vast majority of reported variants are still not understood: ~95 unknown per known disease-causing variant in most modern tests! We need tech for *computational* clinical genetics & genomics interpretation...and @junglainc can help!
Genetic and genomic testing often provides patients with unclear results – @claraya explains how Jungla can help change that for labs, providers, and patients. medium.com/@jungla/bringing-… #genomics #ai #precisionmedicine #beyondsequencing
Jungla Inc. retweeted
Time is often the most valuable resource in the medical community. I'm excited to share that, together, @HPE and @junglainc are aiming to transform the world of medicine as we know it by reducing precious research time from years to weeks. news.hpe.com/hewlett-packard… #HPEDiscover
Jungla Inc. retweeted
ML combined with domain knowledge can push way beyond what ML can do alone. @junglainc combines ML with several other methods, including insights from biophysics, cellular engineering, and distributed systems, to make considerably more accurate predictions of genomic variants.
Genetic and genomic testing often provides patients with unclear results – @claraya explains how Jungla can help change that for labs, providers, and patients. medium.com/@jungla/bringing-… #genomics #ai #precisionmedicine #beyondsequencing
Jungla Inc. retweeted
Learn how @junglainc has developed a cloud-based Molecular Evidence Platform (MEP) to help clinicians and patients understand the results of genetic and genomic tests... buff.ly/2ShTbcR . #IndieBio @SOSVvc
Jungla Inc. retweeted
HPE and biotech startup @junglainc announce challenge to enable real-time, personalized medical care for patients under Tech Impact 2030. Read more: hpe.to/6004EESEm
We are delighted to be working with @HPE to bring state-of-the-art #biophysics and memory-driven computing into quantitative, mechanistic support for #precisionmedicine! With 250x speed-ups (48TB RAM) patients can receive the most advanced support on-demand. #ai #beyondsequencing
Our genes make us who we are, but genetic variations are also a challenge to clinical care. With Memory-Driven Computing, @HPE and @junglainc hope to accelerate research aimed at identifying the correlation between our genes and disease. hpe.to/6007EEUix #HPEDiscover
Jungla Inc. retweeted
Enjoyed visit from @InaldeBS & @IAE_Austral to explore #Innovation-Special thanks to Carlos @junglainc, a #JLABSBay resident company. Shared his experience & work in AI-driven biotechnology to improve #genetic testing. Bonus-he delivered in our guests native language:) @prmansf
Enter an era of high-throughout, quantitative assays of biomolecular function. xitter.gq/wjgreenleaf/status/100…
Our new preprint describing high-throughput protein assays on an Illumina sequencing chip is out; Congrats to Curtis Layton for great work! biorxiv.org/content/early/20…
We are looking forward to the Gordon Research Seminar on Human Genetic Variation and Disease; if you’re excited about the impact of large-scale functional genomics, computational biophysics, and machine learning come meet our CEO @claraya at the Career Development Panel.
Jungla Inc. retweeted
We have a great program this year. @anshulkundaje will be giving the keynote address, 8 exciting talks by junior trainees, and a panel on defining career paths. Panelists include Wei-Lun Alterovitz from @US_FDA , @claraya, @theFourier2k, @LuluP78 and Xin Wang from @23andMe
We are proud to be a part of the growing healthcare innovation efforts that seek to make genomic information more actionable and reliable for all. xitter.gq/JorgeCondeBio/status/9…
Enjoyed chatting w/@GabeOtte @freenome & @claraya @junglainc re: clinical genomics’ promise, peril & price tag @a16z a16z.com/2018/01/11/revisiti…